Relaunch of the Xenios Website – now harmonized with that of its parent, Fresenius Medical Care
The Xenios AG, pioneer in extracorporeal heart and lung support, has restructured its website. Xenios AG has been part of the Fresenius Medical Care Group since 2016 and the new design also serves to bring the company visually in line with the brand image of its parent. www.xenios-ag.com With this ...
View our latest brochure Heart and Lung Assist for Pediatric Patients
View our latest brochure Heart and Lung Assist for Pediatric Patients.
Shaping the future of multi organ support – Novalung and Fresenius Medical Care at the ISICEM Brussels 2019
Shaping the future of multi organ support – Novalung and Fresenius Medical Care at the ISICEM Brussels 2019.
Novalung at ESCIM Paris 2018 – Session and Workshop Report
Novalung at ESCIM Paris 2018 Session and Workshop Report
VV ECMO in severe ARDS: EOLIA trial results show benefit for patients
The results of the ECMO to rescue lung injury in severe ARDS (EOLIA) trial have long been awaited, since the first two trials in this field were already conducted decades ago and the results were controversial. The investigators around Prof. Alain Combes showed now in the largest international randomized multicentre setup so far, that ...
New service area on the Xenios Campus
New service area on the Xenios Campus: eIFUs now available in various languages!
20. – 22. February
29. Symposium Intensivmedizin + Intensivpflege 2019
29. Symposium Intensivmedizin + Intensivpflege 2019 – Bremen, Germany
19. – 22. March
ISICEM 2019 – 39th International Symposium on Intensive Care and Emergency Medicine – Brussels, Belgium
10. – 13. April
8th EuroELSO Congress
8th EuroELSO Congress – Barcelona, Spain
Palau de Congressos de BarcelonaAv. Reina Maria Cristina s/n
Barcelona, 08004 Spain